Recovery from severe frontotemporal dysfunction at 3years after N-methyl-d-aspartic acid (NMDA) receptor antibody encephalitis.

Explore this paper's citation graph

Summary

Although serum antibodies disappeared with recovery in this patient, previous cases have shown serum antibodies to be unreliable markers of disease activity and second-line treatment, especially with substances as well tolerated as rituximab, should at least be considered in NMDA receptor encephalitis with persistent neuropsychiatric syndromes after first-line therapy.

Type
article
Published
2013-04-01
Cited by
17
References
5

Keywords

NMDA receptor, Medicine, Aspartic acid, Antibody, Encephalitis

References

Cited by

Related papers